The use of -blockers, ACE inhibitors/ angiotensin receptor blockers (ARBs), or a combination of both, is associated with decreased mortality among elderly inpatients with congestive heart failure

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.437, 2003-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ACE inhibitors and angiotensin receptor blockers (ARBs) appear to be beneficial in patients with acute renal transplant failure

By  

Inpharma, Vol. 1, Iss. 1573, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Advances in Angiotensin Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs)

By  

Mini Reviews in Medicinal Chemistry, Vol. 3, Iss. 6, 2003-09 ,pp. : 621-631

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of ACE-Inhibitors and Angiotensin Receptor Blockers on Inflammation

By  

Current Pharmaceutical Design, Vol. 18, Iss. 28, 2012-09 ,pp. : 4385-4413

Bentham Science Publishers

Access to resources Recommend Favorite

Demographics, Treatment Regimens and the Use of Angiotensin-receptor Blockers in Heart Failure: Findings from the Valsartan Heart Failure Trial

By Majahalme S  

The Journal of International Medical Research, Vol. 31, Iss. 5, 2003-09 ,pp. : 351-361

Field House Publishing

Access to resources Recommend Favorite

Impact of Home Patient Telemonitoring on Use of β-Blockers in Congestive Heart Failure

By Antonicelli Roberto  

Drugs & Aging, Vol. 27, Iss. 10, 2010-10 ,pp. : 801-805

Adis International

Access to resources Recommend Favorite